Regenxbio (RGNX) EBITDA (2015 - 2026)
Regenxbio's EBITDA was $33.02 million in Q2 2026, compared with -$59.37 million a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) EBITDA (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Regenxbio's EBITDA was -$148.78 million through Jun 30, 2026; for FY2025, it came in at -$145.58 million.
- In earlier years, EBITDA was -$217.13 million in FY2024, -$250.81 million in FY2023, -$249.97 million in FY2022 and $169.58 million in FY2021.
- The Q2 2026 figure marks the highest quarterly EBITDA since Q4 2021.
- Per Business Quant data, RGNX's EBITDA in the three quarters before Q2 2026 was -$79.51 million (Q1 2026), -$53.77 million (Q4 2025) and -$48.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Regenxbio | 418.33 Mn | -341.95 Mn | - | 33.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.02 Mn |
| Mar 31, 2026 | -79.51 Mn |
| Dec 31, 2025 | -53.77 Mn |
| Sep 30, 2025 | -48.53 Mn |
| Jun 30, 2025 | -59.37 Mn |
| Mar 31, 2025 | 16.08 Mn |
| Dec 31, 2024 | -47.35 Mn |
| Sep 30, 2024 | -58.12 Mn |
| Jun 30, 2024 | -51.99 Mn |
| Mar 31, 2024 | -59.68 Mn |
| Dec 31, 2023 | -59.57 Mn |
| Sep 30, 2023 | -60.59 Mn |
| Jun 30, 2023 | -68.67 Mn |
| Mar 31, 2023 | -61.98 Mn |
| Dec 31, 2022 | -53.65 Mn |
| Sep 30, 2022 | -67.50 Mn |
| Jun 30, 2022 | -59.89 Mn |
| Mar 31, 2022 | -68.94 Mn |
| Dec 31, 2021 | 316.24 Mn |
| Sep 30, 2021 | -54.52 Mn |
API Access
Regenxbio EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();